Cohance Lifesciences Market Cap

Cohance Lifesciences has a market cap or net worth of 388.31 billion as of June 10, 2025. Its market cap has increased by 141.93% in one year.

Market Cap

388.31B

Enterprise Value

389.73B

Revenue

11.98B

Ranking

n/a

PE Ratio

97.13

Stock Price

1,015.00

Market Cap Chart

Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 388.31B, an increase of 1,151,971.35%. That is a compound annual growth rate of 492.80%.

Market Cap History

Date	Market Cap	% Change
Jun 9, 2025	392.90B	35.53%
Dec 31, 2024	289.89B	57.55%
Dec 29, 2023	184.00B	46.05%
Dec 30, 2022	125.98B	0.33%
Dec 31, 2021	125.56B	9.05%
Dec 31, 2020	115.14B	341,510.23%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	4,028.96B
Divi's Laboratories	1,737.36B
Cipla	1,214.93B
Apollo Hospitals Enterprise	998.22B
Mankind Pharma	970.77B
Zydus Lifesciences	966.14B
Aurobindo Pharma	674.37B
Alkem Laboratories	581.38B

Market Cap Rankings